Viscardi Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
2
- Exits
-
2

Viscardi Ventures General Information
Company Description
Viscardi Ventures was a venture capital firm based in Munich, Germany. The firm sought to invest in the technology and healthcare sectors. The firm ceased operations on March 15th, 2022.
Business Details
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Munich
- Germany
Viscardi Ventures Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Aegis Analytical | 07-Oct-2005 | Later Stage VC | Automation/Workflow Software | Generating Revenue | ||
Morphochem | 01-Jul-2000 | Biotechnology | Profitable |
Viscardi Ventures Exits (2)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Aegis Analytical | 23-Oct-2012 | Merger/Acquisition | |
Morphochem | 01-Dec-2005 |
Viscardi Ventures Investments by Industry, Year, and Region
Viscardi Ventures FAQs
-
What is Viscardi Ventures?
Viscardi Ventures was a venture capital firm based in Munich, Germany.
-
Where is Viscardi Ventures headquartered?
Viscardi Ventures is headquartered in Munich, Germany.
-
How many investments has Viscardi Ventures made?
Viscardi Ventures has made 2 investments.
-
What has Viscardi Ventures invested in?
Viscardi Ventures has made numerous investments in companies like Aegis Analytical and Morphochem within the Automation/Workflow Software and Biotechnology industries.
-
What has Viscardi Ventures invested in recently?
Viscardi Ventures's latest investment was on 07-Oct-2005 in Aegis Analytical, a company within the Automation/Workflow Software industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »